BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Zhang Y, Zhang L, Dong Y, Ji H, Shen L. The Potential Markers of Circulating microRNAs and long non-coding RNAs in Alzheimer's Disease. Aging Dis 2019;10:1293-301. [PMID: 31788340 DOI: 10.14336/AD.2018.1105] [Cited by in Crossref: 15] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Sisto R, Moleti A, Capone P, Sanjust F, Cerini L, Tranfo G, Massini G, Buscema S, Buscema PM, Chiarella P. MicroRNA expression is associated with auditory dysfunction in workers exposed to ototoxic solvents and noise. Front Public Health 2022;10:958181. [DOI: 10.3389/fpubh.2022.958181] [Reference Citation Analysis]
2 Gao X, Cao Z, Tan H, Li P, Su W, Wan T, Guo W. LncRNA, an Emerging Approach for Neurological Diseases Treatment by Regulating Microglia Polarization. Front Neurosci 2022;16:903472. [DOI: 10.3389/fnins.2022.903472] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Huang R, Sun LJ. Identification of circulating lncRNA in chronic kidney disease based on bioinformatics analysis. Exp Biol Med (Maywood) 2022;:15353702221104035. [PMID: 35757995 DOI: 10.1177/15353702221104035] [Reference Citation Analysis]
4 Guan H, Lv P, Han P, Zhou L, Liu J, Wu W, Yan M, Xing Q, Cao W. Long non‐coding RNA ESCCAL ‐1/ miR ‐590/ LRP6 signaling pathway participates in the progression of esophageal squamous cell carcinoma. Cancer Medicine. [DOI: 10.1002/cam4.4915] [Reference Citation Analysis]
5 Nguyen TPN, Kumar M, Fedele E, Bonanno G, Bonifacino T. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases. Int J Mol Sci 2022;23:4718. [PMID: 35563107 DOI: 10.3390/ijms23094718] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Yan H, Yan Y, Gao Y, Zhang N, Kumar G, Fang Q, Li Z, Li J, Zhang Y, Song L, Wang J, Sun J, Zhang HT, Ma CG. Transcriptome analysis of fasudil treatment in the APPswe/PSEN1dE9 transgenic (APP/PS1) mice model of Alzheimer's disease. Sci Rep 2022;12:6625. [PMID: 35459923 DOI: 10.1038/s41598-022-10554-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Soelter TM, Whitlock JH, Williams AS, Hardigan AA, Lasseigne BN. Nucleic acid liquid biopsies in Alzheimer's disease: current state, challenges, and opportunities. Heliyon 2022;8:e09239. [PMID: 35469332 DOI: 10.1016/j.heliyon.2022.e09239] [Reference Citation Analysis]
8 Duc Nguyen H, Hee Jo W, Hong Minh Hoang N, Kim MS. Anti-inflammatory effects of B vitamins protect against tau hyperphosphorylation and cognitive impairment induced by 1,2 diacetyl benzene: An in vitro and in silico study. Int Immunopharmacol 2022;108:108736. [PMID: 35364429 DOI: 10.1016/j.intimp.2022.108736] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
9 Nguyen HD, Kim MS. Exposure to a mixture of heavy metals induces cognitive impairment: genes and microRNAs involved. Toxicology 2022;:153164. [PMID: 35346790 DOI: 10.1016/j.tox.2022.153164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
10 Medrano-Jiménez E, Meza-Sosa KF, Urbán-Aragón JA, Secundino I, Pedraza-Alva G, Pérez-Martínez L. Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs. J Leukoc Biol 2022. [PMID: 35293018 DOI: 10.1002/JLB.3MR1021-531R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zhao Y, Liu Y, Zhang Q, Liu H, Xu J. The Mechanism Underlying the Regulation of Long Non-coding RNA MEG3 in Cerebral Ischemic Stroke. Cell Mol Neurobiol 2022. [PMID: 34988760 DOI: 10.1007/s10571-021-01176-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Kwak S, Wi J, Lee J, Kim C, Na H. Enhanced detection sensitivity through enzyme-induced precipitate accumulation in LSPR-active nano-valleys. RSC Adv 2022;12:15652-7. [DOI: 10.1039/d2ra01331b] [Reference Citation Analysis]
13 Liu Q, Ling Z, Zhang J, Yu H, Wang Y, Xue Y, Wang C, Zhao J, Cao J, Duan S, Zhao J. lncRNA MIR600HG Knockdown Alleviates Cognitive Impairment in Alzheimer's Disease Through NEDD4L Mediated PINK1 Degradation. J Alzheimers Dis 2021. [PMID: 34958029 DOI: 10.3233/JAD-215194] [Reference Citation Analysis]
14 Song S, Lee JU, Jeon MJ, Kim S, Sim SJ. Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer's disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture. Biosens Bioelectron 2021;199:113864. [PMID: 34890883 DOI: 10.1016/j.bios.2021.113864] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
15 Jia L, Zhu M, Yang J, Pang Y, Wang Q, Li Y, Li T, Li F, Wang Q, Li Y, Wei Y. Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer's disease. BMC Med 2021;19:264. [PMID: 34775974 DOI: 10.1186/s12916-021-02142-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Chum PP, Hakim MA, Behringer EJ. Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model. J Alzheimers Dis 2021. [PMID: 34776451 DOI: 10.3233/JAD-215223] [Reference Citation Analysis]
17 Rybak-Wolf A, Plass M. RNA Dynamics in Alzheimer's Disease. Molecules 2021;26:5113. [PMID: 34500547 DOI: 10.3390/molecules26175113] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Li H, Zou L, Shi J, Han X. Bioinformatics analysis of differentially expressed genes and identification of an miRNA-mRNA network associated with entorhinal cortex and hippocampus in Alzheimer's disease. Hereditas 2021;158:25. [PMID: 34243818 DOI: 10.1186/s41065-021-00190-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 He J, Ling L, Liu Z, Ren X, Wan L, Tu C, Li Z. Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma. Cancer Cell Int 2021;21:313. [PMID: 34130697 DOI: 10.1186/s12935-021-02013-8] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
20 Song Y, Wang X, Hou A, Li H, Lou J, Liu Y, Cao J, Mi W. Integrative Analysis of lncRNA and mRNA and Profiles in Postoperative Delirium Patients. Front Aging Neurosci 2021;13:665935. [PMID: 34093168 DOI: 10.3389/fnagi.2021.665935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Yang Y, Li Y, Yang H, Guo J, Li N. Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson's Disease. Front Mol Neurosci 2021;14:631553. [PMID: 33762908 DOI: 10.3389/fnmol.2021.631553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
22 Culibrk RA, Hahn MS. The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease. Front Aging Neurosci 2020;12:583884. [PMID: 33364931 DOI: 10.3389/fnagi.2020.583884] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
23 Xu X, Cui L, Zhong W, Cai Y. Autophagy-Associated lncRNAs: Promising Targets for Neurological Disease Diagnosis and Therapy. Neural Plast 2020;2020:8881687. [PMID: 33029125 DOI: 10.1155/2020/8881687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
24 Ausó E, Gómez-Vicente V, Esquiva G. Biomarkers for Alzheimer's Disease Early Diagnosis. J Pers Med 2020;10:E114. [PMID: 32899797 DOI: 10.3390/jpm10030114] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
25 Lukiw WJ. microRNA-146a Signaling in Alzheimer's Disease (AD) and Prion Disease (PrD). Front Neurol 2020;11:462. [PMID: 32670176 DOI: 10.3389/fneur.2020.00462] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
26 Lee BK, Kim MH, Lee SY, Son SJ, Hong CH, Jung YS. Downregulated Platelet miR-1233-5p in Patients with Alzheimer's Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin. J Clin Med 2020;9:E1642. [PMID: 32485903 DOI: 10.3390/jcm9061642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Lim KH, Joo JY. Predictive Potential of Circulating Ube2h mRNA as an E2 Ubiquitin-Conjugating Enzyme for Diagnosis or Treatment of Alzheimer's Disease. Int J Mol Sci 2020;21:E3398. [PMID: 32403399 DOI: 10.3390/ijms21093398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
28 Wang J, Chen C, Zhang Y. An investigation of microRNA-103 and microRNA-107 as potential blood-based biomarkers for disease risk and progression of Alzheimer's disease. J Clin Lab Anal 2020;34:e23006. [PMID: 31420923 DOI: 10.1002/jcla.23006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]